Comparison of effect of simvastatin and metformin monotherapy on lipid profile and testosterone levels in polycystic ovary syndrome
Background: Polycystic ovary syndrome has consequences like insulin resistance, hyperandrogenism and dyslipidemia. Metformin is commonly used for treatment of this disorder and its effects on various biochemical parameters are compared with a cardioprotective drug simvastatin. Method: Fifty patients...
Main Author: | Veena Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Makhdoomi Printers
2012-01-01
|
Series: | Global Journal of Medicine and Public Health |
Subjects: | |
Online Access: | http://gjmedph.com/uploads/O4-Vo1No3.pdf |
Similar Items
-
Comparison of effect of simvastatin and metformin monotherapy on lipid profile and testosterone levels in polycystic ovary syndrome
by: Veena Singh, et al.
Published: (2012-06-01) -
Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome
by: Ferdous Mehrabian, et al.
Published: (2016-01-01) -
Changes in peripheral mitochondrial DNA copy number in metformin-treated women with polycystic ovary syndrome: a longitudinal study
by: Po-Kai Yang, et al.
Published: (2020-07-01) -
Polycystic Ovary Induction in Mouse by Testosterone Enanthate
by: Zahra Kalhori, et al.
Published: (2014-03-01) -
The effect of metformin treatment on ICSI in infertile polycystic ovary syndrome
by: Firoozeh Akbari Asbagh, et al.
Published: (2010-03-01)